npj Vaccines

npj Vaccines, Published online: 23 May 2026; doi:10.1038/s41541-026-01494-w Heterologous vaccination with a next-generation vaccinia virus and Ad26 induces Ebola-specific immunity in macaques

npj Vaccines, Published online: 22 May 2026; doi:10.1038/s41541-026-01483-z Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy

npj Vaccines, Published online: 21 May 2026; doi:10.1038/s41541-026-01488-8 The role of naturally occurring and vaccine-induced Ad26 neutralizing antibodies in immunogenicity of Ad26-based vaccines

npj Vaccines, Published online: 20 May 2026; doi:10.1038/s41541-026-01486-w Recent advances in Epstein–Barr virus vaccines development from mechanistic exploration to clinical translation

npj Vaccines, Published online: 19 May 2026; doi:10.1038/s41541-026-01489-7 Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities

npj Vaccines, Published online: 18 May 2026; doi:10.1038/s41541-026-01487-9 Vaccine communication: a critical review of foundations, challenges, and future directions

npj Vaccines, Published online: 16 May 2026; doi:10.1038/s41541-026-01485-x β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

npj Vaccines, Published online: 16 May 2026; doi:10.1038/s41541-026-01484-y Rural-urban differences in oral typhoid vaccine responses in Uganda: contribution of Schistosoma mansoni

npj Vaccines, Published online: 16 May 2026; doi:10.1038/s41541-026-01482-0 Developing a durable, memory-driven, CspZ-targeting Lyme disease vaccine by rationale adjuvant selection

npj Vaccines, Published online: 13 May 2026; doi:10.1038/s41541-026-01481-1 Resurgence of invasive Haemophilus influenzae type b disease in France, 2017–2024: epidemiological, genomic, and immunological insights

npj Vaccines, Published online: 12 May 2026; doi:10.1038/s41541-026-01444-6 A 25-year landscape of Escherichia coli vaccine development: systematic review of human clinical studies

npj Vaccines, Published online: 11 May 2026; doi:10.1038/s41541-026-01440-w A double-blinded, placebo-controlled field trial of an OspA-based oral reservoir targeted vaccine against Borrelia burgdorferi

npj Vaccines, Published online: 11 May 2026; doi:10.1038/s41541-026-01467-z Intranasal boosting enhances genital tract T cell immunity following ChAdOx1/MVA hrHPV therapeutic vaccination

npj Vaccines, Published online: 09 May 2026; doi:10.1038/s41541-026-01465-1 LNP-based delivery of a Toll-like receptor 9 agonist elicits potent adjuvant effects and antitumor immunity

npj Vaccines, Published online: 09 May 2026; doi:10.1038/s41541-026-01479-9 Global patterns of pertussis incidence and vaccination strategies: implications of divergent surveillance data

npj Vaccines, Published online: 08 May 2026; doi:10.1038/s41541-026-01478-w Maturation-deficient chikungunya virus elicits protective immune responses in a murine challenge model

npj Vaccines, Published online: 07 May 2026; doi:10.1038/s41541-026-01475-z A comparison of two- and three-dose MVA-BN mpox vaccination series on anti-monkeypox virus immunity

npj Vaccines, Published online: 05 May 2026; doi:10.1038/s41541-026-01451-7 Monovalent and multivalent OspA mRNA-LNP vaccines elicit functional antibodies and protect against Borrelia burgdorferi in mice

npj Vaccines, Published online: 05 May 2026; doi:10.1038/s41541-026-01458-0 Oral delivery of Trichinella spiralis antigens by yeast-derived β-glucan particles enhances anti-helminth immunity

npj Vaccines, Published online: 06 May 2026; doi:10.1038/s41541-026-01474-0 Advances and future applications of immunocastration techniques: a comprehensive review